X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Science Translational Medicine

期刊標題檢索 SCI TRANSL MED 最新評論: There will definitely be a good outcome! (2024-10-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Science Translational Medicine]您好,您是該頁面的第 170706 位訪客。

期刊簡介
期刊名稱Science Translational Medicine Science Translational Medicine
LetPub Score
9.3
50 ratings
Rate

Reputation
10.0

Influence
9.2

Speed
7.0

期刊簡稱SCI TRANSL MED
ISSN1946-6234
E-ISSN1946-6242
h-index168
CiteScore
CiteScoreSJRSNIPCiteScore Rank
26.706.5102.590
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: General Medicine
Q111 / 636

自引率 (2023-2024)0.60%自引率趨勢
掲載範囲
Science Translational Medicine Mission: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
官方網站http://stm.sciencemag.org/
在線稿件提交https://cts.sciencemag.org/scc/login.html
開放訪問No
出版商American Association for the Advancement of Science
主題領域CELL BIOLOGY
出版國/地區UNITED STATES
發行頻率週刊
創刊年2009
每年文章數271每年文章數趨勢
黃金OA百分比7.22%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ111/205
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ12/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1946-6234%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: Very difficult
參考鏈接
相關期刊 【Science Translational Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Stem Cell Research & TherapyH-index: 56

    CiteScore: 13.20
    Wiley Interdisciplinary Reviews-Nanomedicine and NanobiotechnologyH-index: 0

    CiteScore: 17.60
    EXPERT REVIEWS IN MOLECULAR MEDICINEH-index: 73

    CiteScore: 7.40
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 108

    CiteScore: 11.50
    Frontiers of MedicineH-index: 28

    CiteScore: 18.30
    Journal of Diabetes ResearchH-index: 33

    CiteScore: 8.40
    Biomed Research InternationalH-index: 94

    CiteScore: 6.70
    JOURNAL OF INVESTIGATIVE MEDICINEH-index: 59

    CiteScore: 11.20
    Journal of Cardiovascular Translational ResearchH-index: 44

    CiteScore: 6.10
    American Journal of Translational ResearchH-index: 45

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Biomed Research International398128
    American Journal of Translational Research165370
    Stem Cell Research & Therapy136208
    Frontiers of Medicine89265
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE78945
    Journal of Diabetes Research56540
    Journal of Cardiovascular Translational Research32185
    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology30806
    EXPERT REVIEWS IN MOLECULAR MEDICINE17237
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION16000
  •  

    Science Translational Medicine Science Translational Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [Science Translational Medicine] 的評論撰寫評論
作者: 稻妻向凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-31 17:34:25 評論於
There will definitely be a good outcome!
(0) 讚! | 稻妻向凝

作者: Herbert Lucy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 19:45:29 評論於
Research focus: Translational medicine; Medical experience sharing: It has been almost four months, give a definite answer, whether it is life or death.
(0) 讚! | Herbert Lucy

作者: 奉天睿博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-11 14:03:10 評論於
May I ask if STM requires all authors' agreement to proceed to the next step? The assignment editor has been under evaluation for several days and there has been no change.
(0) 讚! | 奉天睿博

作者: 小野寺心慈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-25 21:56:29 評論於
Not in the same league as cc.
(0) 讚! | 小野寺心慈

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-12 20:07:02 評論於
This is not certain, if you need more information, please contact the editorial department for inquiries.
(0) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-12 14:36:16 評論於
The paper has been submitted to the editorial consultant for review.
(0) 讚! | Adelaide Lawson

作者: 稻妻向凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 15:53:53 評論於
How many external committees are usually appointed?
(0) 讚! | 稻妻向凝

作者: 稻妻向凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-04 22:46:29 評論於
By editing this level, it has been submitted to the external review committee. The next step is to consider the feedback from the external review committee to determine if it should be submitted for review.
(0) 讚! | 稻妻向凝

作者: 削月以松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-04 18:56:02 評論於
There is still some distance compared to CC and NCB.
(0) 讚! | 削月以松

作者: 是你的和洽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-19 22:02:13 評論於
Do all authors need to agree during the initial submission stage?
(0) 讚! | 是你的和洽呀

作者: 是你的和洽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-19 17:55:41 評論於
Is the image inserted into the body of the text?
(0) 讚! | 是你的和洽呀

作者: 是你的和洽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-19 14:05:33 評論於
Can I ask if the submission is to be inserted directly into the body of the text?
(0) 讚! | 是你的和洽呀

作者: 是你的和洽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-19 09:55:41 評論於
Excuse me, is the figure inserted into the text? I did not see a separate place to upload the image.
(0) 讚! | 是你的和洽呀

作者: 是你的和洽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-17 18:09:55 評論於
Do you need to insert images into the body of the text when submitting an article?
(0) 讚! | 是你的和洽呀

作者: 是你的和洽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-17 14:09:36 評論於
May I ask where MDAR is downloaded from when submitting the manuscript?
(0) 讚! | 是你的和洽呀

作者: 澄静云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 15:04:33 評論於
Submitted once, reviewed in about a week, then waited nearly 3 months for the first round of feedback to come back, with one positive and one negative reviewer, ultimately resulting in rejection.
(0) 讚! | 澄静云泽

作者: 西行寺天亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-02 20:08:48 評論於
The flagship journal of the Science family, comparable to Cancer Cell in the Cell family and Nature Cell Biology in the Nature family, and other long-established classic high-impact journals.
(0) 讚! | 西行寺天亦

作者: 打狗靖彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-21 16:00:42 評論於
Has there been a response?
(0) 讚! | 打狗靖彤

作者: 奉天冷风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-16 13:56:15 評論於
I voted on the 9th, and it has been eight days.
(0) 讚! | 奉天冷风

作者: Leila Katrine


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 16:12:45 評論於
What is the status of the advisor?
(0) 讚! | Leila Katrine

作者: 一只红香呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 22:07:42 評論於
Will there be a response from the rejection?
(0) 讚! | 一只红香呀

作者: 仙灵钰岩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 12:47:33 評論於
Please translate the following passage into English and Japanese, with the titles ":" and ":"
(0) 讚! | 仙灵钰岩

作者: 无极红香


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-03 11:31:43 評論於
sadasdasdasdad
(0) 讚! | 无极红香

作者: 京城代晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-28 12:11:43 評論於
Do all authors need to agree during the initial submission stage?
(0) 讚! | 京城代晴

作者: 小野寺英悟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 23:44:16 評論於
Does it always stay under evaluation until the author agrees?
(0) 讚! | 小野寺英悟

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [Science Translational Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*